Skip to main content
Clinical Orthopaedics and Related Research logoLink to Clinical Orthopaedics and Related Research
. 2024 Dec 31;483(2):211–213. doi: 10.1097/CORR.0000000000003360

Value-based Healthcare: The Impact of Consolidation in Healthcare on the Field of Orthopaedic Surgery

Victor C Agbafe 1,2,3, David N Bernstein 4,5, Kevin J Bozic 6,✉
PMCID: PMC11753732  PMID: 39745251

Consolidation in the healthcare services market appears to reduce competition and increase monopolistic practices in the care delivery ecosystem. Proponents argue that consolidation addresses the problem of fragmented care delivery among hospitals and outpatient centers by improving access, utilizing economies of scale to reduce costs, increasing capital investments to fund new technologies, and standardizing clinical processes and protocols to improve quality [1]. However, these purported benefits have largely not come to fruition; instead, economies of scale have resulted in, at best, 4% to 7% cost reductions that shrink to zero when accounting for mergers in the same hospital service area [8], and improvement in quality of care has been inconsistent across care settings [4].

When healthcare entities consolidate at a rapid pace and without sufficient input from physicians, orthopaedic surgeons may experience a loss of autonomy and increased pressure to conform to corporate policies and processes that, in some cases, may not be in the best interest of their patients. Inflicting this kind of moral injury on clinicians can lead to increased feelings of burnout, higher rates of cognitive impairment, early retirement, and low-value care. In other words, the rapid consolidation of healthcare may serve as a barrier to delivering high-value musculoskeletal care. This is why orthopaedic surgeons, regardless of practice setting, should use their platforms and influence to preserve the sanctity of the patient-doctor relationship.

Addressing consolidation in healthcare requires a more competitive ecosystem than the one we have today. To drive greater competition, we propose value-based care solutions that will lower financial barriers to independent (physician-owned) practice, incentivize alternative ownership options for doctors, and increase transparency of both health outcomes and costs.

Encourage Physician-owned Practices

It is hard for many physicians to remain in independent practice due to financial reasons. State and federal laws should alleviate financial pressures on private practices and structure financial incentives in ways that reward high-value care.

At the state level, legislators should aim to pass tax credits that will help support physician-owned practices. A model for this type of legislation is Indiana House Bill 1004 [3], which passed into law on May 4, 2023 and provides primary care practices with a USD 20,000 tax credit for each physician who has an ownership stake in the practice. At the federal level, Medicare payments should be made site-neutral for the same services provided, regardless of location (such as hospital, outpatient departments, independent practices, or ambulatory surgical centers) [5]. A model piece of legislation for this is the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act (PATIENT Act) [7], which passed the House Energy and Commerce Committee with a unanimous 49-0 margin in 2023. Although it has not yet been brought to the full House or Senate for a vote (at the time of writing), if enacted into law, this bill would implement site neutrality for services provided in hospital off-campus outpatient departments and independent practices. It also would create site neutrality in Medicare reimbursement for medications administered in those locations.

Incentivize Alternative Ownership and Employment Options

Policymakers should also incentivize alternative ownership or employment routes for physicians outside of the hospital-employed model. One option is to promote physician-owned hospital structures and partnerships. Federal House Resolution 977 (Patient Access to Higher Quality Health Care Act of 2023) [6] would accomplish this by removing Stark law provisions that ban Medicare payments to physician-owned hospitals. Stark laws were put in place to prevent a conflict of interest in clinical decision-making that could arise from the financial upside of “self-referring” to other practices that a physician owns and to mitigate the impact of healthcare fraud. However, it is clear that existing Stark laws are serving as a barrier for physicians who would like to transition toward value-based care arrangements, thereby limiting competition in healthcare. This legislative proposal has been introduced in the House Energy and Commerce Committee and House Ways and Means Committee (at the time of writing), but it has not been brought up for a vote in either committee.

Additionally, improving access to capital for physician groups would make it easier for physicians to invest in healthcare facilities like imaging centers, ambulatory surgery centers, and rehabilitation facilities. Sources of this capital could include targeted grant programs for physicians who aim to buy investments in geographically underserved areas or targeted tax credits for equipment purchases. Physicians can create and seek funding from physician-focused investment funds or seek out specialized loan programs from banks and credit unions.

Finally, the Federal Trade Commission (FTC) should proceed with and vigorously enforce its plan to ban noncompete clauses and rescind existing noncompete clauses [10]. Enforcement should ensure that nondisclosure agreements (NDAs) and “garden leave” policies do not cross the line into becoming functional restricted covenants. (A garden leave policy refers to an employer policy that forbids a former employee from working for a competitor or starting a competing business for a certain period of time—usually weeks to months—following the conclusion of one’s employment in exchange for receiving full payment or benefits during employment.)

Of course, none of these measures will be successful if physicians are not trained in organizational management. Without this foundational education, they will face a competitive disadvantage relative to their peers with formal business and legal training when it comes to managing large teams and organizations. To remedy this, leaders of orthopaedic surgical societies should partner with local and regional experts to create opportunities for surgeons to be exposed to finance and management principles, with a focus on how these principles impact the value of care delivered to patients and the well-being of both patients and clinicians.

Increase Disclosure Requirements

Legislators should continue with the implementation of hospital price transparency measures—with an emphasis on prices that can be interpreted by patients—and expand those measures to cover physician practices. The US Department of Health and Human Services (HHS) should also seek to expand the existing mandatory ownership reporting requirements that apply to nursing homes to all doctors, hospitals, and health systems. A bill that was introduced in 2023, House Resolution 3262 [9], would require hospitals, freestanding emergency centers, ambulatory surgical centers, physician practices with more than 25 physicians, physician practices owned by hospitals, insurance companies, and other entities to disclose their ownership. While this bill is a positive step forward, we believe that this requirement should apply to practices of all sizes.

Further, state medical boards should pass laws mandating the disclosure of physician practices that are under stock transfer restriction agreements, which is a key contractual legal agreement underpinning private equity ownership structures [2]. These agreements require a medical doctor to transfer ownership of his or her shares of a broader management service organization—which is set up by the private equity-owned company that acquired the practice—under certain conditions, including when the management service organization requests it. This allows the management service organization to effectively replace and appoint another physician to lead the professional medical corporation at will. In other words, despite a physician having ownership of certain shares in the management service organization, it is the private equity sponsor who controls the transfer of the shares, in effect giving the sponsor organizational and management control. This management service organization setup allows private equity firms to bypass state corporate practice of medicine doctrines regarding physician ownership of medical practices, and the restricted stock transfer agreement gives the private equity company the power to dictate when and where to sell the practice and its assets off to a secondary buyer.

Will This All Be Worth It?

There is a chance that our proposed solutions may fail to drive competition for physician services and improve patient health outcomes. The financial and time costs of implementing these measures may put further strain on independent physician practices, exacerbating the very issues they aim to address. However, our solutions still offer a strong return on investment, as transparency measures would force increasingly consolidated care delivery entities—owned by private equity or not—to disclose information that would enable patients and physicians to make the best financial- and health-related decisions. Further, alleviating financial pressures on private practices will make it more likely that, one day, federal payment policy will not determine where a patient can seek care.

This is why we must advocate for care decisions that prioritize the health of the patient. Orthopaedic surgeons may benefit from joining and participating in organizations whose actions impact the financial bottom lines of their platforms or practices, such as state orthopaedic medical societies and national organizations (like the American Academy of Orthopaedic Surgeons, American Orthopaedic Association, and the American Medical Association). Leaders of orthopaedic surgical societies should partner with financial experts to create structured education on how consolidation is impacting care delivery, patient outcomes, and clinicians. New financial incentives should be structured to reward patient-centered behavior and competition, not consolidation. We cannot guarantee that a more competitive care delivery ecosystem will improve health outcomes, but we believe more competition in healthcare based on value delivered to patients would be beneficial to all.

Footnotes

A note from the Editor-in-Chief: We are pleased to present to readers of Clinical Orthopaedics and Related Research® the latest “Value-based Healthcare” column (formerly “Orthopaedic Healthcare Worldwide”). “Value-based Healthcare” explores strategies to enhance the value of musculoskeletal care by improving health outcomes and reducing the overall cost of care delivery. We welcome reader feedback on all of our columns and articles; please send your comments to eic@clinorthop.org.

Each author certifies that there are no funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article related to the author or any immediate family members.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.

The opinions expressed are those of the writers, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.

Contributor Information

Victor C. Agbafe, Email: victoragbafe@gmail.com.

David N. Bernstein, Email: bernsteindavidn@gmail.com.

References


Articles from Clinical Orthopaedics and Related Research are provided here courtesy of The Association of Bone and Joint Surgeons

RESOURCES